Kheïra Beldjord

Université Paris Cité — France

Medicine · Health Sciences

41h-index9.5kcitations119works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(46), Acute Lymphoblastic Leukemia research(40), Chronic Myeloid Leukemia Treatments(23), Acute Myeloid Leukemia Research(20), Chronic Lymphocytic Leukemia Research(17)

Publications119 total

<i>Erratum</i> to: Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
Haematologica·2025Open Access
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
Haematologica·2024· 4 citedOpen Access
Supplementary Figure 2 from T Cell Receptor Genotyping and <i>HOXA/TLX1</i> Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
2023Open Access
Supplementary Table 1 from T Cell Receptor Genotyping and <i>HOXA/TLX1</i> Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
2023Open Access
Data from T Cell Receptor Genotyping and <i>HOXA/TLX1</i> Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
2023Open Access
Supplementary Figure 1 from T Cell Receptor Genotyping and <i>HOXA/TLX1</i> Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
2023Open Access
Supplementary Table 1 from T Cell Receptor Genotyping and <i>HOXA/TLX1</i> Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
2023Open Access
Supplementary Figure 1 from T Cell Receptor Genotyping and <i>HOXA/TLX1</i> Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
2023Open Access
Supplementary Figure 2 from T Cell Receptor Genotyping and <i>HOXA/TLX1</i> Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
2023Open Access
Data from T Cell Receptor Genotyping and <i>HOXA/TLX1</i> Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
2023Open Access
FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY
Hematological Oncology·2019· 7 cited
A New and Simple TRG Multiplex PCR Assay for Assessment of T‐cell Clonality: A Comparative Study from the EuroClonality Consortium
HemaSphere·2019· 16 citedOpen Access
Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study
Blood Cancer Journal·2016· 41 citedOpen Access
Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia
New England Journal of Medicine·2016· 340 citedOpen Access
Interleukin-15-Dependent T-Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease
Immunity·2016· 150 citedOpen Access
Efficacy of ibrutinib in the treatment of <scp>B</scp>ing–<scp>N</scp>eel syndrome
American Journal of Hematology·2015· 45 citedOpen Access
Addition of Rituximab Improves the Outcome of Adult Patients with CD20-Positive, Ph-Negative, B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Graall-R 2005 Study
Blood·2015· 44 cited
Regulatory CD4&lt;sup&gt;+&lt;/sup&gt; CD25&lt;sup&gt;+&lt;/sup&gt; FoxP3&lt;sup&gt;+&lt;/sup&gt; T Cells Are Expanded in the Peripheral Blood of LCH Patients
Figshare·2015Open Access
The p16INK4A/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome
Leukemia Research·2015· 8 cited
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia
Blood·2015· 265 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Elizabeth Macintyre(24), Vahid Asnafi(17), Éric Delabesse(13), Hervé Dombret(11), Norbert Ifrah(10), Françoise Huguet(9), Xavier Thomas(8), Véronique Lhéritier(8), Yves Chalandon(7), Patrice Chevallier(6), Agnès Buzyn(6), Marie C. Béné(6), Jean Soulier(5), Emmanuelle Clappier(5), Marina Cavazzana(5), Hélène Cavé(5), Jacques J. M. van Dongen(5), Marie‐Hélène Delfau‐Larue(5), Olivier Hermine(5), Isabelle André‐Schmutz(5)